Devex: Opinion: To end HIV/AIDS, the U.K. and U.S. should lead the way
Deborah Waterhouse, chief executive officer of ViiV Healthcare, and Charles “Chip” Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation

“…Recognizing the Global Fund’s critical role in tackling the world’s greatest infectious diseases — both as a donor and as a catalyst making other organizations’ lifesaving work possible — we call upon our countries’ leaders to make pledges that will sustain this global partnership and inspire other nations to support its continued impact. While the U.S. directly funds programs that support the HIV response in other countries, it still bears a particularly important responsibility in replenishing the collectively financed Global Fund. Legally, every dollar the U.S. contributes must be matched by a minimum of two dollars from the rest of the world — meaning robust American investment can serve as leverage compelling other countries to donate generously or leave U.S. dollars unclaimed. The United Kingdom’s most significant investment in ending HIV is through the Global Fund. As a historically generous donor, the U.K. can and should uphold that proud legacy. … The U.K. and U.S. should lead the charge to secure an HIV free future for everyone — everywhere — by fully supporting the Global Fund’s investment target” (6/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.